Chemoinformaics analysis of Lupinisoflavone N
| Molecular Weight | 472.49 | nRot | 5 |
| Heavy Atom Molecular Weight | 444.266 | nRig | 22 |
| Exact Molecular Weight | 472.173 | nRing | 4 |
| Solubility: LogS | -3.222 | nHRing | 2 |
| Solubility: LogP | 2.737 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 67.6382 |
| nHD | 6 | BPOL | 32.4298 |
| QED | 0.327 |
| Synth | 4.127 |
| Natural Product Likeliness | 2.387 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.902 |
| HIA | 0.298 |
| CACO-2 | -5.605 |
| MDCK | 0.00000661 |
| BBB | 0.009 |
| PPB | 0.95937 |
| VDSS | 0.406 |
| FU | 0.0412313 |
| CYP1A2-inh | 0.075 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.214 |
| CYP2c9-sub | 0.582 |
| CYP2d6-inh | 0.336 |
| CYP2d6-sub | 0.185 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.119 |
| CL | 4.807 |
| T12 | 0.617 |
| hERG | 0.017 |
| Ames | 0.084 |
| ROA | 0.431 |
| SkinSen | 0.544 |
| Carcinogencity | 0.048 |
| EI | 0.052 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.862 |
| Antiviral | Yes |
| Prediction | 0.783861 |